Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Down To Earth filed an RTI application to find out the reason of vaccine shortage in India. The response revealed how a plan to promote private vaccine makers boomeranged. The health ministry was forced to get vaccines illegally from the very public sector manufacturers it suspended last year Shuvam Kumar …
Official admission In December 2008, a team of health ministry officials toured 13 states to review the National Rural Health Mission. They found, among other things, hospitals in Bihar did not have vaccines for diphtheria, whooping cough and tetanus. The review also reported shortages in Assam, where measles vaccine was …
cyrus s poonawalla, chairperson and managing director of Serum Institute of India Ltd, a private vaccine manufacturer, says the vaccine shortage is a mess the government created. Edited excerpts: On self-sufficiency: Except for polio vaccine, we can provide all vaccines required for the Universal Immunization Programme. Whatever orders were placed …
Strengthen public sector The lack of foresight shown by former health minister Anbumani Ramadoss in shutting the public sector without first ensuring alternatives and lack of transparency have put a generation of children at risk. Clearly, the private sector
Dubious vitamin drive: A committee investigating reports of deaths and illnesses following a nationwide campaign promoting vitamin A and de-worming medicines in Bangladesh said the tablets were safe. The government had launched the investigation after two children died and 400 fell sick soon after consuming the tablets. Some 20 million …
US-BASED vaccine maker Novavax, that is developing a vaccine for Swine Flu, will conduct a major portion of the clinical trials in India. The trials will be conducted from September in joint collaboration with Ahmedabadbased drug major Cadila Pharmaceuticals. Talking to ET, Rahul Singhvi president & CEO Novavax said:
Guidelines Only Up To Pre-Clinical Stage THE department of biotechnology (DBT) is planning to set up National Biotechnology Regulatory Board to specify and regulate development of drugs and vaccines from natural sources, such as humans, animals or micro-organism, a DBT official said.
Solan: The pharmaceutical hub of Baddi-Barotiwala-Nalagarh has been left high and dry with the budget failing to address any of their grievances, including hike in the excise duty and refund on raw materials. Since the gains of the 2003 Central industrial package had been reduced after two reductions in the …
Stroke kills around 5.5 million people every year, worldwide. Two-thirds of these deaths take place in developing countries like India. An estimate of cardiovascular disease (CVD) deaths in India suggests that 52 per cent of CVD deaths occur among people below 70 years as compared to 23 per cent in …
NEW DELHI: Doctors in the Capital have given the green signal to the Sanofi-Aventis insulin drug Lantus, the use of which has come under question after a report about the drug being linked to a raised risk of cancer.
International studies published last week linked a very widely used synthetic insulin to increased risk of cancer. But millions of Indian diabetes patients who use the drug have reason to be relieved after the US Food and Drug Administration (FDA)
A patent is an exclusive right awarded by the intellectual property (IP) authority of a state to an inventor or his assignee for a limited period of time in lieu of disclosure of an invention for the benefit of mankind. In recent times, it has become a practice by a …
